Subventions financées

This research proposal investigates how a chemical modification called N6-methyladenosine (m6A) on messenger RNA influences brain health, specifically focusing on its role in sleep regulation, learning and memory, and neurodegenerative diseases such as Alzheimer’s.

At birth, some babies suffer from a condition called birth asphyxia, where their brain and organs do not receive enough oxygen or blood, leading to hypoxic-ischemic encephalopathy (HIE).

Periodontal disease has links with Alzheimer’s disease.

Many of the challenges faced by both basic and clinical neuroscientists, such as ensuring the reproducibility of important findings and the representation of underserved populations, can be tackled with Open Science approaches

In Canada, about 1.1 million people care for family members with dementia, providing support that saves the healthcare system billions each year.

Recent findings suggest that the gut and brain are closely connected, and this link may be important in Alzheimer’s disease (AD).

The Douglas-Bell Canada Brain Bank (DBCBB; douglasbrainbank.ca), based at the Douglas Research Centre (McGill University affiliate), has become one of the most important brain banks in the world.

Caring for a family member with a neurodevelopmental disability (NDD) can be challenging, often leading to high levels of anxiety and depression.

Glioblastoma Multiforme (GBM) is the most common and aggressive brain tumour in adults.

Optogenetics, defined as a technique where light-sensitive genes are introduced into brain cells to control their activity with light, allows researchers to precisely control nerve cell communication thereby, transforming brain research.